Alejandro Luna

Alejandro Luna
Alejandro joined OLIVARES in 1996 and became a partner in 2005. He Co-chairs the Life Sciences & Pharmaceutical law and industry group and also he coordinates the litigation department. Alejandro has been crucial to the heart of Mexico’s intellectual property legal system as one of the few true patent-regulatory lit- igation experts in Mexico. Alejandro has spearheaded a ten-year litigation strategy that has incorporated regulation changes and lobbying which has resulted in an important precedent for the patent linkage regulation and life terms of pipeline patents in Mexico. As a result of his involvement, he has been selected as the …
Alejandro joined OLIVARES in 1996 and became a partner in 2005. He Co-chairs the Life Sciences & Pharmaceutical law and industry group and also he coordinates the litigation department. Alejandro has been crucial to the heart of Mexico’s intellectual property legal system as one of the few true patent-regulatory lit- igation experts in Mexico.

Alejandro has spearheaded a ten-year litigation strategy that has incorporated regulation changes and lobbying which has resulted in an important precedent for the patent linkage regulation and life terms of pipeline patents in Mexico. As a result of his involvement, he has been selected as the delegate to represent AMIIF, the indus- try association for R&D pharmaceutical companies who do busi- ness in Mexico, in the Trans-Pacific Partnership (TPP) negotiations.

Alejandro has successfully litigated for pharmaceutical patents and pioneered administrative court actions to seek recognition of DPE rights (protection for safety and efficacy data), which are not specifically recognized by Mexican laws
See more

Articles